{"pre_text": ["bhge 2017 form 10-k | 103 part iii item 10 .", "directors , executive officers and corporate governance information regarding our code of conduct , the spirit and the letter , and code of ethical conduct certificates for our principal executive officer , principal financial officer and principal accounting officer are described in item 1 .", "business of this annual report .", "information concerning our directors is set forth in the sections entitled \"proposal no .", "1 , election of directors - board nominees for directors\" and \"corporate governance - committees of the board\" in our definitive proxy statement for the 2018 annual meeting of stockholders to be filed with the sec pursuant to the exchange act within 120 days of the end of our fiscal year on december 31 , 2017 ( \"proxy statement\" ) , which sections are incorporated herein by reference .", "for information regarding our executive officers , see \"item 1 .", "business - executive officers of baker hughes\" in this annual report on form 10-k .", "additional information regarding compliance by directors and executive officers with section 16 ( a ) of the exchange act is set forth under the section entitled \"section 16 ( a ) beneficial ownership reporting compliance\" in our proxy statement , which section is incorporated herein by reference .", "item 11 .", "executive compensation information for this item is set forth in the following sections of our proxy statement , which sections are incorporated herein by reference : \"compensation discussion and analysis\" \"director compensation\" \"compensation committee interlocks and insider participation\" and \"compensation committee report.\" item 12 .", "security ownership of certain beneficial owners and management and related stockholder matters information concerning security ownership of certain beneficial owners and our management is set forth in the sections entitled \"stock ownership of certain beneficial owners\" and 201cstock ownership of section 16 ( a ) director and executive officers 201d ) in our proxy statement , which sections are incorporated herein by reference .", "we permit our employees , officers and directors to enter into written trading plans complying with rule 10b5-1 under the exchange act .", "rule 10b5-1 provides criteria under which such an individual may establish a prearranged plan to buy or sell a specified number of shares of a company's stock over a set period of time .", "any such plan must be entered into in good faith at a time when the individual is not in possession of material , nonpublic information .", "if an individual establishes a plan satisfying the requirements of rule 10b5-1 , such individual's subsequent receipt of material , nonpublic information will not prevent transactions under the plan from being executed .", "certain of our officers have advised us that they have and may enter into stock sales plans for the sale of shares of our class a common stock which are intended to comply with the requirements of rule 10b5-1 of the exchange act .", "in addition , the company has and may in the future enter into repurchases of our class a common stock under a plan that complies with rule 10b5-1 or rule 10b-18 of the exchange act .", "equity compensation plan information the information in the following table is presented as of december 31 , 2017 with respect to shares of our class a common stock that may be issued under our lti plan which has been approved by our stockholders ( in millions , except per share prices ) .", "equity compensation plan category number of securities to be issued upon exercise of outstanding options , warrants and rights weighted average exercise price of outstanding options , warrants and rights number of securities remaining available for future issuance under equity compensation plans ( excluding securities reflected in the first column ) ."], "post_text": ["."], "table": [["equity compensation plancategory", "number ofsecurities to beissued uponexercise ofoutstandingoptions warrantsand rights", "weighted averageexercise price ofoutstandingoptions warrantsand rights", "number of securitiesremaining availablefor future issuanceunder equitycompensation plans ( excluding securitiesreflected in the firstcolumn )"], ["stockholder-approved plans", "1.6", "$ 36.61", "53.7"], ["nonstockholder-approved plans", "2014", "2014", "2014"], ["total", "1.6", "$ 36.61", "53.7"]], "table_ori": [["Equity Compensation PlanCategory", "Number ofSecurities to beIssued UponExercise ofOutstandingOptions, Warrantsand Rights", "Weighted AverageExercise Price ofOutstandingOptions, Warrantsand Rights", "Number of SecuritiesRemaining Availablefor Future IssuanceUnder EquityCompensation Plans(excluding securitiesreflected in the firstcolumn)"], ["Stockholder-approved plans", "1.6", "$36.61", "53.7"], ["Nonstockholder-approved plans", "—", "—", "—"], ["Total", "1.6", "$36.61", "53.7"]]}

Question: what portion of the approved securities is to be issued upon exercise of outstanding options warrants rights?
Evidence:
table_1: equity compensation plancategory the stockholder-approved plans of number ofsecurities to beissued uponexercise ofoutstandingoptions warrantsand rights is 1.6 ; the stockholder-approved plans of weighted averageexercise price ofoutstandingoptions warrantsand rights is $ 36.61 ; the stockholder-approved plans of number of securitiesremaining availablefor future issuanceunder equitycompensation plans ( excluding securitiesreflected in the firstcolumn ) is 53.7 ;
Program: add(1.6, 53.7), divide(1.6, #0)
Answer:
str_answer: 2.9%
exe_answer: 0.02893